Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

R.L. Coleman; D. Lorusso; C. Gennigens; A. González-Martín; L. Randall; D. Cibula; B. Lund; L. Woelber; S. Pignata; F. Forget; A. Redondo; R. Rangwala; S.D. Vindeløv; M. Chen; J.R. Harris; L. Nicacio; M.S.L. Teng; M. Smith; B.J. Monk; I.B. Vergote

doi:10.1016/j.annonc.2020.08.2262

Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

R.L. Coleman, D. Lorusso, C. Gennigens, A. González-Martín, L. Randall, D. Cibula, B. Lund, L. Woelber, S. Pignata, F. Forget, A. Redondo, R. Rangwala, S.D. Vindeløv, M. Chen, J.R. Harris, L. Nicacio, M.S.L. Teng, M. Smith, B.J. Monk, I.B. Vergote

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	31
Udgave nummer	Suppl. 4
Sider (fra-til)	S1162-S1163
Antal sider	2
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2020.08.2262
Status	Udgivet - 1 sep. 2020
Begivenhed	ESMO Virtual Congress 2020 - Virtual Varighed: 19 sep. 2020 → 21 sep. 2020 https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020

Konference

Konference	ESMO Virtual Congress 2020
Lokation	Virtual
Periode	19/09/2020 → 21/09/2020
Internetadresse	https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020

Adgang til dokumentet

10.1016/j.annonc.2020.08.2262

Citationsformater

Coleman, R. L., Lorusso, D., Gennigens, C., González-Martín, A., Randall, L., Cibula, D., Lund, B., Woelber, L., Pignata, S., Forget, F., Redondo, A., Rangwala, R., Vindeløv, S. D., Chen, M., Harris, J. R., Nicacio, L., Teng, M. S. L., Smith, M., Monk, B. J., & Vergote, I. B. (2020). Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study. Annals of Oncology, 31(Suppl. 4), S1162-S1163. https://doi.org/10.1016/j.annonc.2020.08.2262

Coleman, R.L. ; Lorusso, D. ; Gennigens, C. ; González-Martín, A. ; Randall, L. ; Cibula, D. ; Lund, B. ; Woelber, L. ; Pignata, S. ; Forget, F. ; Redondo, A. ; Rangwala, R. ; Vindeløv, S.D. ; Chen, M. ; Harris, J.R. ; Nicacio, L. ; Teng, M.S.L. ; Smith, M. ; Monk, B.J. ; Vergote, I.B. / Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer : Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study. I: Annals of Oncology. 2020 ; Bind 31, Nr. Suppl. 4. s. S1162-S1163.

@article{6db43e87ed424cd6a2e0fdae9e137349,

title = "Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study",

author = "R.L. Coleman and D. Lorusso and C. Gennigens and A. Gonz{\'a}lez-Mart{\'i}n and L. Randall and D. Cibula and B. Lund and L. Woelber and S. Pignata and F. Forget and A. Redondo and R. Rangwala and S.D. Vindel{\o}v and M. Chen and J.R. Harris and L. Nicacio and M.S.L. Teng and M. Smith and B.J. Monk and I.B. Vergote",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.annonc.2020.08.2262",

language = "English",

volume = "31",

pages = "S1162--S1163",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 4",

note = "null ; Conference date: 19-09-2020 Through 21-09-2020",

url = "https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020",

}

Coleman, RL, Lorusso, D, Gennigens, C, González-Martín, A, Randall, L, Cibula, D, Lund, B, Woelber, L, Pignata, S, Forget, F, Redondo, A, Rangwala, R, Vindeløv, SD, Chen, M, Harris, JR, Nicacio, L, Teng, MSL, Smith, M, Monk, BJ & Vergote, IB 2020, 'Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study', Annals of Oncology, bind 31, nr. Suppl. 4, s. S1162-S1163. https://doi.org/10.1016/j.annonc.2020.08.2262

Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer : Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study. / Coleman, R.L.; Lorusso, D.; Gennigens, C.; González-Martín, A.; Randall, L.; Cibula, D.; Lund, B.; Woelber, L.; Pignata, S.; Forget, F.; Redondo, A.; Rangwala, R.; Vindeløv, S.D.; Chen, M.; Harris, J.R.; Nicacio, L.; Teng, M.S.L.; Smith, M.; Monk, B.J.; Vergote, I.B.

I: Annals of Oncology, Bind 31, Nr. Suppl. 4, 01.09.2020, s. S1162-S1163.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer

AU - Coleman, R.L.

AU - Lorusso, D.

AU - Gennigens, C.

AU - González-Martín, A.

AU - Randall, L.

AU - Cibula, D.

AU - Lund, B.

AU - Woelber, L.

AU - Pignata, S.

AU - Forget, F.

AU - Redondo, A.

AU - Rangwala, R.

AU - Vindeløv, S.D.

AU - Chen, M.

AU - Harris, J.R.

AU - Nicacio, L.

AU - Teng, M.S.L.

AU - Smith, M.

AU - Monk, B.J.

AU - Vergote, I.B.

PY - 2020/9/1

Y1 - 2020/9/1

U2 - 10.1016/j.annonc.2020.08.2262

DO - 10.1016/j.annonc.2020.08.2262

M3 - Conference abstract in journal

VL - 31

SP - S1162-S1163

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - Suppl. 4

Y2 - 19 September 2020 through 21 September 2020

ER -